Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells

David H. Holman, Lorianne S. Turner, Ahmed El-Zawahry, Saeed Elojeimy, Xiang Liu, Jacek Bielawski, Zdzislaw M. Szulc, Kristi Norris, Youssef Zeidan, Yusuf A. Hannun, Alicja Bielawska, James S. Norris

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Purpose: Alterations in ceramide metabolism have been reported in prostate cancer (PCa), resulting in escape of cancer cells from ceramide-induced apoptosis. Specifically, increased expression of lysosomal acid ceramidase (AC) has been shown in some primary PCa tissues and in several PCa cell lines. To determine if this represents a novel therapeutic target, we designed and synthesized LCL204, a lysosomotropic analog of B13, a previously reported inhibitor of AC Methods: Prostate cancer cell lines were treated with LCL204 for varying times and concentrations. Effects of treatment on cytotoxicity, sphingolipid content, and apoptotic markers were assessed. Results: Treatment of DU145 PCa cells resulted in increased ceramide and decreased sphingosine levels. Interestingly, LCL204 caused degradation of AC in a cathepsin-dependent manner. We also observed rapid destabilization of lysosomes and the release of lysosomal proteases into the cytosol following treatment with LCL204. Combined, these events resulted in mitochondria depolarization and executioner caspase activation, ultimately ending in apoptosis Conclusions: These results provide evidence that treatment with molecules such as LCL204, which restore ceramide levels in PCa cells may serve as a new viable treatment option for PCa.

Original languageEnglish (US)
Pages (from-to)231-242
Number of pages12
JournalCancer Chemotherapy and Pharmacology
Volume61
Issue number2
DOIs
StatePublished - Feb 2008
Externally publishedYes

Fingerprint

Acid Ceramidase
Ceramides
Prostatic Neoplasms
Cells
Apoptosis
Cathepsins
Sphingolipids
Mitochondria
Sphingosine
Depolarization
Cytotoxicity
Caspases
Metabolism
Peptide Hydrolases
Chemical activation
Cell Line
Tissue
Degradation
Molecules
Lysosomes

Keywords

  • Acid ceramidase inhibitors
  • Apoptosis
  • B13
  • Ceramide
  • LCL204
  • Lysosomes

ASJC Scopus subject areas

  • Cancer Research
  • Pharmacology
  • Oncology

Cite this

Holman, D. H., Turner, L. S., El-Zawahry, A., Elojeimy, S., Liu, X., Bielawski, J., ... Norris, J. S. (2008). Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. Cancer Chemotherapy and Pharmacology, 61(2), 231-242. https://doi.org/10.1007/s00280-007-0465-0

Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. / Holman, David H.; Turner, Lorianne S.; El-Zawahry, Ahmed; Elojeimy, Saeed; Liu, Xiang; Bielawski, Jacek; Szulc, Zdzislaw M.; Norris, Kristi; Zeidan, Youssef; Hannun, Yusuf A.; Bielawska, Alicja; Norris, James S.

In: Cancer Chemotherapy and Pharmacology, Vol. 61, No. 2, 02.2008, p. 231-242.

Research output: Contribution to journalArticle

Holman, DH, Turner, LS, El-Zawahry, A, Elojeimy, S, Liu, X, Bielawski, J, Szulc, ZM, Norris, K, Zeidan, Y, Hannun, YA, Bielawska, A & Norris, JS 2008, 'Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells', Cancer Chemotherapy and Pharmacology, vol. 61, no. 2, pp. 231-242. https://doi.org/10.1007/s00280-007-0465-0
Holman, David H. ; Turner, Lorianne S. ; El-Zawahry, Ahmed ; Elojeimy, Saeed ; Liu, Xiang ; Bielawski, Jacek ; Szulc, Zdzislaw M. ; Norris, Kristi ; Zeidan, Youssef ; Hannun, Yusuf A. ; Bielawska, Alicja ; Norris, James S. / Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells. In: Cancer Chemotherapy and Pharmacology. 2008 ; Vol. 61, No. 2. pp. 231-242.
@article{74360a16cc4149838adeff39895be713,
title = "Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells",
abstract = "Purpose: Alterations in ceramide metabolism have been reported in prostate cancer (PCa), resulting in escape of cancer cells from ceramide-induced apoptosis. Specifically, increased expression of lysosomal acid ceramidase (AC) has been shown in some primary PCa tissues and in several PCa cell lines. To determine if this represents a novel therapeutic target, we designed and synthesized LCL204, a lysosomotropic analog of B13, a previously reported inhibitor of AC Methods: Prostate cancer cell lines were treated with LCL204 for varying times and concentrations. Effects of treatment on cytotoxicity, sphingolipid content, and apoptotic markers were assessed. Results: Treatment of DU145 PCa cells resulted in increased ceramide and decreased sphingosine levels. Interestingly, LCL204 caused degradation of AC in a cathepsin-dependent manner. We also observed rapid destabilization of lysosomes and the release of lysosomal proteases into the cytosol following treatment with LCL204. Combined, these events resulted in mitochondria depolarization and executioner caspase activation, ultimately ending in apoptosis Conclusions: These results provide evidence that treatment with molecules such as LCL204, which restore ceramide levels in PCa cells may serve as a new viable treatment option for PCa.",
keywords = "Acid ceramidase inhibitors, Apoptosis, B13, Ceramide, LCL204, Lysosomes",
author = "Holman, {David H.} and Turner, {Lorianne S.} and Ahmed El-Zawahry and Saeed Elojeimy and Xiang Liu and Jacek Bielawski and Szulc, {Zdzislaw M.} and Kristi Norris and Youssef Zeidan and Hannun, {Yusuf A.} and Alicja Bielawska and Norris, {James S.}",
year = "2008",
month = "2",
doi = "10.1007/s00280-007-0465-0",
language = "English (US)",
volume = "61",
pages = "231--242",
journal = "Cancer Chemotherapy and Pharmacology",
issn = "0344-5704",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells

AU - Holman, David H.

AU - Turner, Lorianne S.

AU - El-Zawahry, Ahmed

AU - Elojeimy, Saeed

AU - Liu, Xiang

AU - Bielawski, Jacek

AU - Szulc, Zdzislaw M.

AU - Norris, Kristi

AU - Zeidan, Youssef

AU - Hannun, Yusuf A.

AU - Bielawska, Alicja

AU - Norris, James S.

PY - 2008/2

Y1 - 2008/2

N2 - Purpose: Alterations in ceramide metabolism have been reported in prostate cancer (PCa), resulting in escape of cancer cells from ceramide-induced apoptosis. Specifically, increased expression of lysosomal acid ceramidase (AC) has been shown in some primary PCa tissues and in several PCa cell lines. To determine if this represents a novel therapeutic target, we designed and synthesized LCL204, a lysosomotropic analog of B13, a previously reported inhibitor of AC Methods: Prostate cancer cell lines were treated with LCL204 for varying times and concentrations. Effects of treatment on cytotoxicity, sphingolipid content, and apoptotic markers were assessed. Results: Treatment of DU145 PCa cells resulted in increased ceramide and decreased sphingosine levels. Interestingly, LCL204 caused degradation of AC in a cathepsin-dependent manner. We also observed rapid destabilization of lysosomes and the release of lysosomal proteases into the cytosol following treatment with LCL204. Combined, these events resulted in mitochondria depolarization and executioner caspase activation, ultimately ending in apoptosis Conclusions: These results provide evidence that treatment with molecules such as LCL204, which restore ceramide levels in PCa cells may serve as a new viable treatment option for PCa.

AB - Purpose: Alterations in ceramide metabolism have been reported in prostate cancer (PCa), resulting in escape of cancer cells from ceramide-induced apoptosis. Specifically, increased expression of lysosomal acid ceramidase (AC) has been shown in some primary PCa tissues and in several PCa cell lines. To determine if this represents a novel therapeutic target, we designed and synthesized LCL204, a lysosomotropic analog of B13, a previously reported inhibitor of AC Methods: Prostate cancer cell lines were treated with LCL204 for varying times and concentrations. Effects of treatment on cytotoxicity, sphingolipid content, and apoptotic markers were assessed. Results: Treatment of DU145 PCa cells resulted in increased ceramide and decreased sphingosine levels. Interestingly, LCL204 caused degradation of AC in a cathepsin-dependent manner. We also observed rapid destabilization of lysosomes and the release of lysosomal proteases into the cytosol following treatment with LCL204. Combined, these events resulted in mitochondria depolarization and executioner caspase activation, ultimately ending in apoptosis Conclusions: These results provide evidence that treatment with molecules such as LCL204, which restore ceramide levels in PCa cells may serve as a new viable treatment option for PCa.

KW - Acid ceramidase inhibitors

KW - Apoptosis

KW - B13

KW - Ceramide

KW - LCL204

KW - Lysosomes

UR - http://www.scopus.com/inward/record.url?scp=36349008127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36349008127&partnerID=8YFLogxK

U2 - 10.1007/s00280-007-0465-0

DO - 10.1007/s00280-007-0465-0

M3 - Article

VL - 61

SP - 231

EP - 242

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

SN - 0344-5704

IS - 2

ER -